Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who is CVSI's D&O insurance carrier?
Provide a link to documentation of current coverage.
I'm curious, in light of the following:
Cannabis Directors and Officers Liability: Cause for Optimism?
Here's "REALITY":
https://www.natlawreview.com/article/settlement-structures-residual-funds-attorneys-fees-and-reverters-part-i
How Many GNC Stores offer CVSciences' products?
NOT THAT MANY, given CHAPTER 11 and SALES RESTRICTIONS:
CHAPTER 11:
GNC Completes Chapter 11 Plan Process
CVSI vs CWBHF:Corporate Performance and SharePrice
(RECALL: Charlotte's Web completed its IPO August 30, 2018.)
CVSI :
December 31, 2018:
Shareholder Equity: $30.1M
Share Price: $4.31
September 30, 2021:
Shareholder Equity: $11.1M (0.37 times the December 2018 value)
December 28, 2021:
Share Price: $0.12 (0.03 times the December 2018 value)
COMPARE TO
CWBHF:
December 31, 2018:
Shareholder Equity: $121.5M
Share Price: $11.11
September 30, 2021:
Shareholder Equity: $241.7M (1.99 times the December 2018 value)
December 28, 2021:
Share Price: $1.12 (0.10 times the December 2018 value)
NOTE:
1. CVSI SHARE PRICE DECLINE is consistent with its SHAREHOLDER EQUITY DECLINE between 2018 and 2021.
2. CWBHF SHARE PRICE DECLINE, though proportionately less than CVSI's, is completely INCONSISTENT with its DOUBLING of SHAREHOLDER EQUITY between 2018 and 2021.
3. Eventually, CWBHF share price should reflect its corporate performance.
4. Unfortunately for CVSI holders, CVSI share price DOES reflect its corporate performance.
CWBHF vs CVSI:Corporate Performance and SharePrice
(RECALL: Charlotte's Web completed its IPO August 30, 2018.)
CWBHF:
December 31, 2018:
Shareholder Equity: $121.5M
Share Price: $11.11
September 30, 2021:
Shareholder Equity: $241.7M (1.99 times the December 2018 value)
December 28, 2021:
Share Price: $1.12 (0.10 times the December 2018 value)
COMPARE TO
CVSI :
December 31, 2018:
Shareholder Equity: $30.1M
Share Price: $4.31
September 30, 2021:
Shareholder Equity: $11.1M (0.37 times the December 2018 value)
December 28, 2021:
Share Price: $0.12 (0.03 times the December 2018 value)
NOTE:
1. CVSI SHARE PRICE DECLINE is consistent with its SHAREHOLDER EQUITY DECLINE between 2018 and 2021.
2. CWBHF SHARE PRICE DECLINE, though proportionately less than CVSI's, is completely INCONSISTENT with its DOUBLING of SHAREHOLDER EQUITY between 2018 and 2021.
3. Eventually, CWBHF share price should reflect its corporate performance.
4. Unfortunately for CVSI holders, CVSI share price DOES reflect its corporate performance.
CVSI Shareholder DILUTION HAPPENING NOW
RIGHT NOW, in the context of a multi-year declining CVSI share price, existing CVSI shareholders are being subjected to TWO(2) highly DILUTIVE Share Purchase Agreements (SPAs): 1) The $10M TUMIM DILUTION and 2) The CONVERTIBLE NOTE DILUTION (5 tranches, $5.3M total) with a "FULL RATCHET" provision.
With CVSI in DIME ($0.10) territory, just how many shares do 'ya 'spose those $MILLIONS ultimately will buy?
ANSWER: LOTS and LOTS of 10's of MILLIONS.
And just how much DILUTION for earlier shareholders will result?
ANSWER: LOTS and LOTS of 10's of MILLIONS.
CV Sciences
REVENUES CASH
( $M ) ( $M )
2018
Q2 12.3 3.3
Q3 13.6 11.0
Q4 14.2 12.7
2019
Q1 14.9 13.6
Q2 16.9 15.7
Q3 12.6 14.2
Q4 9.4 9.6
2020
Q1 8.3 7.6
Q2 5.4 8.1 *
Q3 5.6 6.1 *
Q4 5.2 4.5 *
2021
Q1 4.8 5.7 *
Q2 5.1 3.0 *
Q3 5.1 1.7 *
CVSI slide to OBLIVION makes sense
CVSI's slide is consistent with its ABYSMAL corporate performance and will continue.
CIRCLING THE DRAIN
CWBHF's slide is not consistent with its corporate performance and ultimately will be corrected.
Compare Business Performance of CVSI to CWBHF
CVSciences has NO HEMP products on Amazon:
https://www.amazon.com/s?k=%22cv+sciences%22+%22hemp%22
Charlotte's Web has HEMP products on Amazon
https://www.amazon.com/s?k=%22charlotte%27s+web%22+%22hemp%22
Charlotte's Web has HEMP products on Amazon
https://www.amazon.com/s?k=%22charlotte%27s+web%22+%22hemp%22
CV Sciences has NO HEMP products on Amazon:
https://www.amazon.com/s?k=%22cv+sciences%22+%22hemp%22
Walmart removed the 3rd-party seller items
Here's one of those October posts about it:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166389811
NOPE. . . Again
https://www.amazon.com/Hemyum-Hemp-Seed-Oil
These finances don't attract BIG BOX stores:
investorshub.advfn.com/boards/read_msg.aspx?message_id=167167088
Compare Business Performances of CWBHF and CVSI
Since its IPO in August 2018, Charlotte's Web's REVENUES HAVE GROWN MUCH HIGHER than CV Sciences' and its SHAREHOLDERS' EQUITY HAS NEARLY TRIPLED, while CV Sciences' has fallen precipitously.
SEROUSLY, do the CV Sciences' numbers look like those of a WALMART PARTNER ??!!:
CV Sciences' 2021 Q3 Report
Charlotte's Web's 2021 Q3 Report
From 12/31/2019 through 09/30/21 :
CV Sciences' SHAREHOLDERS' EQUITY DECREASED from $29.1M to $11.1M.
Charlotte's Web's SHAREHOLDERS' EQUITY INCREASED from $153.7M to $241.7M.
COMPARING REVENUES AND CASH:
CV Sciences Charlotte's Web
REVENUES CASH REVENUES CASH
( $M ) ( $M ) ( $M ) ( $M )
2018
Q2 12.3 3.3 17.2 10.8
Q3 13.6 11.0 17.7 79.4 <--IPO
Q4 14.2 12.7 21.5 73.4
2019
Q1 14.9 13.6 21.7 69.1
Q2 16.9 15.7 25.0 51.4
Q3 12.6 14.2 25.1 35.0
Q4 9.4 9.6 22.8 68.6
2020
Q1 8.3 7.6 21.5 53.0
Q2 5.4 8.1 * 21.6 99.8
Q3 5.6 6.1 * 25.2 65.9
Q4 5.2 4.5 * 26.9 52.8
2021
Q1 4.8 5.7 * 23.4 35.0 **
Q2 5.1 3.0 * 24.2 27.1 **
Q3 5.1 1.7 * 23.7 21.1 **
That is an OLD screenshot image
That is NOT an image of an active Walmart site.
It is an OLD image of items that have been removed because they violated Walmart's CBD ban.
That was discussed in October:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166232647
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166234972
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166258260
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166258457
NOTICE ON THAT 1ST LINK ABOVE, THE LINKED WALMART PAGE FROM OCTOBER HAS BEEN REMOVED.
That is the page in the "screenshot" -- it's no longer on the Walmart website.
That is an OLD screenshot image
That is NOT an image of an active Walmart site.
It is an OLD image of items that have been removed because they violated Walmart's CBD ban.
That was discussed on this message board in October:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166232647
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166234972
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166258260
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166258457
NOTICE ON THAT 1ST LINK ABOVE, THE LINKED WALMART PAGE FROM OCTOBER HAS BEEN REMOVED.
That is the page in the "screenshot" -- it's no longer on the Walmart website.
Nope.
For example:
Typical Hemp Oil on Amazon
WALMART SELLS NO CV SCIENCES PRODUCTS
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167257593
1. The two Walmart links purporting to be for a CV Sciences' CBD-based product result in a version (there are several) of Walmart's "Uh-oh" page:
2. Both Walmart and Amazon currently BAN ALL CBD SUPPLEMENTS.
Walmart
Prove it
There's ALWAYS "tomorrow" etc, etc.
Walmart CBD Prohibition Remains NATIONWIDE following FDA
Walmart Marketplace Prohibited Dietary Supplements:
CV Sciences, GNC, and Competition
GNC Completes Chapter 11 Plan Process
I believe GE_Jim is referring to:
Page 88 in
https://www.sec.gov/Archives/edgar/data/0001750155/000110465921134530/tm2126643d1_1012g.htm#h_001
Darth, here are links to the page images:
https://pbs.twimg.com/media/FGwbCHGXMAglUxv?format=jpg&name=small
https://pbs.twimg.com/media/FGwbCe7X0AQXOc7?format=jpg&name=small
I DON'T KNOW WHY the 2 links you provided don't go directly to the 2 pages of the letter. It looked to me like they should. But I'm not a "twitter person". :)
CV Sciences is "Circling the Drain" :
A. Multi-year DECLINING 1)REVENUES 2)CASH 3)SHAREHOLDER EQUITY. See Here.
B. Currently, in the context of a multi-year declining CVSI share price, existing CVSI shareholders are being subjected to TWO(2) highly DILUTIVE Share Purchase Agreements (SPAs): 1) The $10M TUMIM DILUTION and 2) The CONVERTIBLE NOTE DILUTION (5 tranches, $5.3M total) with a "FULL RATCHET" provision.
C. Low trading volume with the falling share price effectively has "LOCKED IN" many on this board whose large holdings, if sold, could crater the share price even further. Daily DOLLAR VOLUME is typically under $50K !!! How can large holders sell into THAT??!!
But what about CV Sciences' MANAGEMENT TEAM? They're sure NOT "LOCKED IN".
Two recently-packed "GOLDEN PARACHUTES" (Section 280G of the Internal Revenue Code) are ready for deployment:
1. June 23, 2021
CVSI vs CWBHF: COMPARING REVENUES AND CASH
CVSI HAS BEEN ON A DECLINE FOR YEARS.
CV Sciences Charlotte's Web
REVENUES CASH REVENUES CASH
( $M ) ( $M ) ( $M ) ( $M )
2018
Q2 12.3 3.3 17.2 10.8
Q3 13.6 11.0 17.7 79.4 <--IPO
Q4 14.2 12.7 21.5 73.4
2019
Q1 14.9 13.6 21.7 69.1
Q2 16.9 15.7 25.0 51.4
Q3 12.6 14.2 25.1 35.0
Q4 9.4 9.6 22.8 68.6
2020
Q1 8.3 7.6 21.5 53.0
Q2 5.4 8.1 * 21.6 99.8
Q3 5.6 6.1 * 25.2 65.9
Q4 5.2 4.5 * 26.9 52.8
2021
Q1 4.8 5.7 * 23.4 35.0 **
Q2 5.1 3.0 * 24.2 27.1 **
Q3 5.1 1.7 * 23.7 21.1 **
CWBHF vs CVSI:Corporate Performance and SharePrice
(RECALL: Charlotte's Web completed its IPO August 30, 2018.)
CWBHF:
December 31, 2018:
Shareholder Equity: $121.5M
Share Price: $11.11
September 30, 2021:
Shareholder Equity: $241.7M (1.99 times the December 2018 value)
December 16, 2021:
Share Price: $1.03 (0.09 times the December 2018 value)
COMPARE TO
CVSI :
December 31, 2018:
Shareholder Equity: $30.1M
Share Price: $4.31
September 30, 2021:
Shareholder Equity: $11.1M (0.37 times the December 2018 value)
December 16, 2021:
Share Price: $0.12 (0.03 times the December 2018 value)
NOTE:
1. CVSI SHARE PRICE DECLINE is consistent with its SHAREHOLDER EQUITY DECLINE between 2018 and 2021.
2. CWBHF SHARE PRICE DECLINE, though proportionately less than CVSI's, is completely INCONSISTENT with its DOUBLING of SHAREHOLDER EQUITY between 2018 and 2021.
3. Eventually, CWBHF share price should reflect its corporate performance.
4. Unfortunately for CVSI holders, CVSI share price DOES reflect its corporate performance.
CVSI vs CWBHF:Corporate Performance and SharePrice
(RECALL: Charlotte's Web completed its IPO August 30, 2018.)
CVSI :
December 31, 2018:
Shareholder Equity: $30.1M
Share Price: $4.31
September 30, 2021:
Shareholder Equity: $11.1M (0.37 times the December 2018 value)
December 16, 2021:
Share Price: $0.12 (0.03 times the December 2018 value)
COMPARE TO
CWBHF:
December 31, 2018:
Shareholder Equity: $121.5M
Share Price: $11.11
September 30, 2021:
Shareholder Equity: $241.7M (1.99 times the December 2018 value)
December 16, 2021:
Share Price: $1.03 (0.09 times the December 2018 value)
NOTE:
1. CVSI SHARE PRICE DECLINE is consistent with its SHAREHOLDER EQUITY DECLINE between 2018 and 2021.
2. CWBHF SHARE PRICE DECLINE, though proportionately less than CVSI's, is completely INCONSISTENT with its DOUBLING of SHAREHOLDER EQUITY between 2018 and 2021.
3. Eventually, CWBHF share price should reflect its corporate performance.
4. Unfortunately for CVSI holders, CVSI share price DOES reflect its corporate performance.
CVSciences vs Charlotte's Web: Financials
CV Sciences' 2021 Q3 Report
Charlotte's Web's 2021 Q3 Report
From 12/31/2019 through 09/30/21 :
CV Sciences' SHAREHOLDERS' EQUITY DECREASED from $29.1M to $11.1M.
Charlotte's Web's SHAREHOLDERS' EQUITY INCREASED from $153.7M to $241.7M.
COMPARING REVENUES AND CASH:
CV Sciences Charlotte's Web
REVENUES CASH REVENUES CASH
( $M ) ( $M ) ( $M ) ( $M )
2018
Q2 12.3 3.3 17.2 10.8
Q3 13.6 11.0 17.7 79.4 <--IPO
Q4 14.2 12.7 21.5 73.4
2019
Q1 14.9 13.6 21.7 69.1
Q2 16.9 15.7 25.0 51.4
Q3 12.6 14.2 25.1 35.0
Q4 9.4 9.6 22.8 68.6
2020
Q1 8.3 7.6 21.5 53.0
Q2 5.4 8.1 * 21.6 99.8
Q3 5.6 6.1 * 25.2 65.9
Q4 5.2 4.5 * 26.9 52.8
2021
Q1 4.8 5.7 * 23.4 35.0 **
Q2 5.1 3.0 * 24.2 27.1 **
Q3 5.1 1.7 * 23.7 21.1 **
CVSciences is, essentially, a ZOMBIE company.
A. Multi-year DECLINING 1)REVENUES 2)CASH 3)SHAREHOLDER EQUITY.
See Here.
B. Currently, in the context of a multi-year declining CVSI share price, existing CVSI shareholders are being subjected to TWO(2) highly DILUTIVE Share Purchase Agreements (SPAs): 1) The $10M TUMIM DILUTION and 2) The CONVERTIBLE NOTE (5 tranches, $5.3M total) with a "FULL RATCHET" provision.
C. Low trading volume with the falling share price effectively has "LOCKED IN" many on this board whose large holdings, if sold, could crater the share price even further. Look at last week's trading:
Daily Dollar Volume is generally well under $50K !!!
How can large holders possibly sell into THAT ??!! With such low volume, quoted share price spreads are virtually USELESS to them.
But what about CV Sciences' MANAGEMENT TEAM? They're sure NOT "LOCKED IN".
Two recently-packed "GOLDEN PARACHUTES" (Section 280G of the Internal Revenue Code) are ready for deployment:
1. June 23, 2021
That claim is simply NOT TRUE:
'Wolf-man jack' claimed:
Here's the link to that Feb2021 article:
https://www.nutritionaloutlook.com/view/covid-19-plus-legal-uncertainty-slowed-cbd-sales-in-2020-what-s-cbd-in-for-in-2021-2021-ingredient-trends-to-watch-for-food-drinks-and-dietary-supplements
In NO WAY does that article or its author support YOUR statements about "the return usage rate of a CBD user".
Implying that they do is plainly dishonest.
No wonder you didn't provide the link yourself.
CBD Sales 2014_2022 Published 09_10_2021
https://www.statista.com/statistics/760498/total-us-cbd-sales/
Same "problem" with C2H5OH :